Detalhe da pesquisa
1.
Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.
J Virol
; 87(9): 5028-40, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23427151
2.
Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon.
J Virol
; 87(9): 5041-52, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23427153
3.
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Theranostics
; 12(1): 1-17, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987630
4.
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
ACS Cent Sci
; 8(5): 527-545, 2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35647275
5.
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.
Nat Protoc
; 16(6): 3114-3140, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893470
6.
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
Br J Pharmacol
; 178(3): 626-635, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125711
7.
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.
Nat Commun
; 12(1): 5469, 2021 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552091
8.
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
Nat Commun
; 12(1): 542, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483491
9.
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.
Nat Commun
; 12(1): 81, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398055
10.
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.
EClinicalMedicine
; 31: 100689, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392485
11.
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19.
Nat Commun
; 12(1): 1260, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627662
12.
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
Nat Commun
; 11(1): 4198, 2020 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826914
13.
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Nat Struct Mol Biol
; 27(11): 1094, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060850
14.
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.
Nat Struct Mol Biol
; 27(10): 950-958, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737466
15.
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Nat Struct Mol Biol
; 27(9): 846-854, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661423
16.
Immunogenicity of a DNA vaccine candidate for COVID-19.
Nat Commun
; 11(1): 2601, 2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433465
17.
COVID-19 vaccinations for children.
Lancet Infect Dis
; 22(9): 1255-1256, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760075
18.
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Nat Struct Mol Biol
; 28(3): 326, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536566
19.
Short communication: pitfalls of culturing C8166 cells in serum-free media.
AIDS Res Hum Retroviruses
; 21(3): 246-8, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15795532
20.
Construction of FWPV Chimaeric MVA.
Bio Protoc
; 5(1)2015 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082275